SCHEMBL7976237

SCHEMBL7976237

C=C1N(c2ccccc2)CCN1c1cc2cc(Cl)ccc2nc1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MAPT P10636 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
FAAH O00519 2/20 0.34
CYP1A2 P05177 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
HTR3A P46098 2/20 0.33
HRH4 Q9H3N8 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966498 0.82 HRH4 (0.40) SMN1; SMN2NPC1RAB9AMAPTADORA3
SCHEMBL7979410 0.72 DAO (0.44) SMN1; SMN2NPC1RAB9AMAPTADORA3
SCHEMBL10140203 0.68 MAT2A (0.44) SMN1; SMN2NPC1RAB9AADORA3ADORA2A
SCHEMBL10133974 0.68 SIGMAR1 (0.58) SMN1; SMN2NPC1RAB9AMAPTKDM4E
SCHEMBL31577611 0.68 KDM4E (0.60) SMN1; SMN2NPC1RAB9AMAPTADORA3
SCHEMBL4640583 0.62 HRH4 (0.43) SMN1; SMN2NPC1RAB9AMAPTADORA3
SCHEMBL11043888 0.61 KDM4E (0.51) SMN1; SMN2MAPTADORA3ADORA2ACYP1A2
SCHEMBL22447052 0.60 SIGMAR1 (0.52) NPC1RAB9AMAPTHTR3AMEN1
SCHEMBL7969172 0.59 NPC1 (0.53) SMN1; SMN2NPC1RAB9AMAPTKDM4E
SCHEMBL7974649 0.59 MEN1 (0.47) SMN1; SMN2NPC1RAB9AMAPTADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed